4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-19-024503
Director bought 1,526 shares at an average $6.13 ($9,351)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Galante Joseph C Director | 2019-04-01 | Purchase | +382 | $5.99 | $2,288 | 8,732 | D |
| Galante Joseph C Director | 2019-04-02 | Purchase | +580 | $6.12 | $3,550 | 9,312 | D |
| Galante Joseph C Director | 2019-04-03 | Purchase | +80 | $6.00 | $480 | 9,392 | D |
| Galante Joseph C Director | 2018-04-04 | Purchase | +241 | $6.19 | $1,492 | 9,633 | D |
| Galante Joseph C Director | 2019-04-05 | Purchase | +183 | $6.32 | $1,157 | 9,816 | D |
| Galante Joseph C Director | 2019-04-09 | Purchase | +60 | $6.41 | $385 | 9,876 | D |
| Open-market purchases · 1,526 sh · avg $6.13 · $9,351 | |||||||
Loading xslF345X03/doc4.xml…